BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 28698390)

  • 21. Effect of neuromuscular taping on musculoskeletal disorders secondary to the use of aromatase inhibitors in breast cancer survivors: a pragmatic randomised clinical trial.
    Conejo I; Pajares B; Alba E; Cuesta-Vargas AI
    BMC Complement Altern Med; 2018 Jun; 18(1):180. PubMed ID: 29890985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Yoga versus massage in the treatment of aromatase inhibitor-associated knee joint pain in breast cancer survivors: a randomized controlled trial.
    Tsai CL; Liu LC; Liao CY; Liao WL; Liu YH; Hsieh CL
    Sci Rep; 2021 Jul; 11(1):14843. PubMed ID: 34290337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study.
    Arem H; Sorkin M; Cartmel B; Fiellin M; Capozza S; Harrigan M; Ercolano E; Zhou Y; Sanft T; Gross C; Schmitz K; Neogi T; Hershman D; Ligibel J; Irwin ML
    J Cancer Surviv; 2016 Aug; 10(4):654-62. PubMed ID: 26782031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic options for aromatase inhibitor-associated arthralgia in breast cancer survivors: A systematic review of systematic reviews, evidence mapping, and network meta-analysis.
    Kim TH; Kang JW; Lee TH
    Maturitas; 2018 Dec; 118():29-37. PubMed ID: 30415752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interventions for the Treatment of Aromatase Inhibitor-Associated Arthralgia in Breast Cancer Survivors: A Systematic Review and Meta-analysis.
    Yang GS; Kim HJ; Griffith KA; Zhu S; Dorsey SG; Renn CL
    Cancer Nurs; 2017; 40(4):E26-E41. PubMed ID: 27333128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Joint pain and falls among women with breast cancer on aromatase inhibitors.
    Basal C; Vertosick E; Gillis TA; Li Q; Bao T; Vickers A; Mao JJ
    Support Care Cancer; 2019 Jun; 27(6):2195-2202. PubMed ID: 30306326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Effect of Exercise on the Alleviation of Side Effects Induced by Aromatase Inhibitors in Postmenopausal Breast Cancer Patients.
    Raptopoulos Z; Constantinou C
    Curr Oncol Rep; 2020 Aug; 22(11):110. PubMed ID: 32803384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Acupuncture vs Sham Acupuncture or Waiting List Control in the Treatment of Aromatase Inhibitor-Related Joint Pain: A Randomized Clinical Trial.
    Hershman DL; Unger JM; Greenlee H; Capodice J; Lew DL; Darke A; Minasian LM; Fisch MJ; Henry NL; Crew KD
    JAMA Netw Open; 2022 Nov; 5(11):e2241720. PubMed ID: 36367721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomised trial of electro-acupuncture for arthralgia related to aromatase inhibitor use.
    Mao JJ; Xie SX; Farrar JT; Stricker CT; Bowman MA; Bruner D; DeMichele A
    Eur J Cancer; 2014 Jan; 50(2):267-76. PubMed ID: 24210070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparing exercise responses to aerobic plus resistance training between postmenopausal breast cancer survivors undergoing aromatase inhibitor therapy and healthy women.
    de Paulo TRS; Winters-Stone KM; Viezel J; Rossi FE; Aro BL; Trindade ACAC; Codogno JS; Freitas Junior IF
    Disabil Rehabil; 2019 Sep; 41(18):2175-2182. PubMed ID: 29644889
    [No Abstract]   [Full Text] [Related]  

  • 31. Identification of tools to measure changes in musculoskeletal symptoms and physical functioning in women with breast cancer receiving aromatase inhibitors.
    Swenson KK; Nissen MJ; Henly SJ; Maybon L; Pupkes J; Zwicky K; Tsai ML; Shapiro AC
    Oncol Nurs Forum; 2013 Nov; 40(6):549-57. PubMed ID: 24161633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness, safety, and economic evaluation of adjuvant moxibustion therapy for aromatase inhibitor-induced arthralgia of postmenopausal breast cancer stage I to III patients: Study protocol for a prospective, randomized, assessor-blind, usual-care controlled, parallel-group, pilot clinical trial.
    Shin S; Jang BH; Park SH; Lee JW; Chae MS; Kim N; Suh HS; Han S; Min SY; Baek SK; Lim YJ; Hwang DS
    Medicine (Baltimore); 2019 Sep; 98(38):e17260. PubMed ID: 31568000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment with Ruta graveolens 5CH and Rhus toxicodendron 9CH may reduce joint pain and stiffness linked to aromatase inhibitors in women with early breast cancer: results of a pilot observational study.
    Karp JC; Sanchez C; Guilbert P; Mina W; Demonceaux A; Curé H
    Homeopathy; 2016 Nov; 105(4):299-308. PubMed ID: 27914569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Arthralgia during aromatase inhibitor treatment in early breast cancer patients: prevalence, impact, and recognition by healthcare providers.
    Boonstra A; van Zadelhoff J; Timmer-Bonte A; Ottevanger PB; Beurskens CH; van Laarhoven HW
    Cancer Nurs; 2013; 36(1):52-9. PubMed ID: 22495502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Omega-3 fatty acid use for obese breast cancer patients with aromatase inhibitor-related arthralgia (SWOG S0927).
    Shen S; Unger JM; Crew KD; Till C; Greenlee H; Gralow J; Dakhil SR; Minasian LM; Wade JL; Fisch MJ; Henry NL; Hershman DL
    Breast Cancer Res Treat; 2018 Dec; 172(3):603-610. PubMed ID: 30159789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aromatase inhibitor-associated arthralgia syndrome.
    Burstein HJ
    Breast; 2007 Jun; 16(3):223-34. PubMed ID: 17368903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Aromatase inhibitors and arthralgia].
    Nagykálnai T; Landherr L; Mészáros E
    Magy Onkol; 2011 Mar; 55(1):32-9. PubMed ID: 21617789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aromatase inhibitor-induced arthralgia: clinical experience and treatment recommendations.
    Coleman RE; Bolten WW; Lansdown M; Dale S; Jackisch C; Merkel D; Maass N; Hadji P
    Cancer Treat Rev; 2008 May; 34(3):275-82. PubMed ID: 18082328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase II study of glucosamine with chondroitin on aromatase inhibitor-associated joint symptoms in women with breast cancer.
    Greenlee H; Crew KD; Shao T; Kranwinkel G; Kalinsky K; Maurer M; Brafman L; Insel B; Tsai WY; Hershman DL
    Support Care Cancer; 2013 Apr; 21(4):1077-87. PubMed ID: 23111941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time course of arthralgia among women initiating aromatase inhibitor therapy and a postmenopausal comparison group in a prospective cohort.
    Castel LD; Hartmann KE; Mayer IA; Saville BR; Alvarez J; Boomershine CS; Abramson VG; Chakravarthy AB; Friedman DL; Cella DF
    Cancer; 2013 Jul; 119(13):2375-82. PubMed ID: 23575918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.